Andion CH4 Renewables Srl has reached financial close on a €67 million ($78.9 million) facility to support the development of its near-term biomethane projects in Italy and the Nordic region.
The financing has been provided by Private Credit at Goldman Sachs Alternatives, marking a step forward in Andion’s strategy to scale its biomethane platform across Europe. Existing shareholders also made a significant equity contribution, led by Equitix.
The transaction was arranged by Carlingford, with BNP Paribas acting as financial adviser. Legal advisers included GSK Stockman, De Berti Jacchia and Cirio.
The investment comes as the European biogas sector expands in response to energy security concerns and climate policy initiatives, including REPowerEU and the EU’s Fit for 55 targets. Biogas and biomethane projects are increasingly viewed as key infrastructure, converting organic waste into renewable gas for industry, transport and power, while reducing methane emissions.
Jonas Martin-Löf, Chief Executive and Chairman of Andion, said the transaction reflects confidence in the company’s team, technology and ability to develop and operate biogas projects at scale. Christian Schaefer, Managing Director and Co-Head of Climate Credit at Goldman Sachs Alternatives, said the tailored private credit structure would support the next phase of growth.
Equitix’s Oskar Backman added that the investor continues to back Andion’s management and strategic plan as the company expands its European footprint.
